Four key areas are identified where the streamline of data and reports can help improve the reporting and collaboration of clinical trial sites:
- -Access to more investigators
- -Reduction of non-performing sites
- -Decrease in time for feasibility and site identification
- -Expand access for clinical researchers to research opportunities
Have you participated in streamlining your clinical data? What are some of the benefits you see in addition to the four identified by EPC?
Data transparency is rising to the top of many conversations - streamlining investigator sites is just one. This April at Partnerships in Clinical Trials, we'll bring together some of the key companies in Pharma including Boehringer Ingelheim, Pfizer, UCB Pharma, Center for Medicine in the Public Interest and GlaxoSmithKline during the panel Show Me Your Data: How Transparency is Driving Drug Development to look at how streamlining and sharing data can improve clinical trials throughout the drug industry. For more information on this session, download the agenda. If you'd like to join us April 22-24 in Boston, as a reader of this blog, when you register to join us and mention code XP2000BL, you can save $100 off the current rate!